Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
3 studies found for:    15911865 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Alternative Dosing for CRLX101 Alone, With Avastin and With mFOLFOX6 in Advanced Solid Tumors
Condition: Solid Tumors
Interventions: Drug: CRLX101;   Drug: Bevacizumab;   Drug: mFOLFOX6
2 Not yet recruiting Evaluation of TRANSKRIP ® Plus Chemotherapy in Recurrent-Persistent Cervical Cancer
Condition: Cervical Cancer
Interventions: Drug: Hydralazine/Magnesium;   Drug: Placebo;   Drug: Carboplatin;   Drug: Paclitaxel
3 Completed Comparison of Three Chemotherapy Regimens in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer
Condition: Cervical Cancer
Interventions: Drug: cisplatin;   Drug: topotecan hydrochloride

Study has passed its completion date and status has not been verified in more than two years.